WEKO3
アイテム
{"_buckets": {"deposit": "76445e04-4c3c-4e0f-8ad7-4a5a304f2a05"}, "_deposit": {"created_by": 3, "id": "1273", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "1273"}, "status": "published"}, "_oai": {"id": "oai:dmu.repo.nii.ac.jp:00001273", "sets": ["75"]}, "author_link": ["6324", "6327", "6325", "6323", "6322", "6320", "6321", "6326"], "item_2_biblio_info_12": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2015-10-25", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "3", "bibliographicPageEnd": "150", "bibliographicPageStart": "143", "bibliographicVolumeNumber": "42", "bibliographic_titles": [{"bibliographic_title": "Dokkyo journal of medical sciences"}]}]}, "item_2_description_10": {"attribute_name": "抄録(日)", "attribute_value_mlt": [{"subitem_description": "乳癌の個別化治療が進む中で,依然としてエストロゲンレセプター (ER) やHER2遺伝子の発現状況と化学療法の薬剤感受性との関係には不明な点が多い.今回我々はCollagen gel Droplet embedded culture Drug Sensitivity Test (CD-DST法) を用いた抗癌剤感受性試験を行い,乳癌のsubtypeと薬剤感受性の関係について検討を行った.対象は乳癌患者60例59検体で,5-FUは34検体,epirubicinは35検体,paclitaxelは29検体で抗癌剤感受性の評価が可能であった.5-FU,epirubicin,paclitaxelいずれの薬剤においてもHER2発現状況と抗癌剤感受性との間に有意な相関は認められなかった.ERの発現を認めるホルモン陽性乳癌ではepirubicinに対する薬剤感受性が有意に低下し,5-FU,paclitaxelに対しても感受性が低い傾向が認められた.術前化学療法施行例では抗癌剤感受性試験の評価可能率が低下する事が判明した.CD-DST法は今後の乳癌化学療法を選択する上で,有用となりうる可能性が示唆された.", "subitem_description_type": "Other"}]}, "item_2_description_11": {"attribute_name": "抄録(英)", "attribute_value_mlt": [{"subitem_description": "Breast cancer is classified into four subtypes according to estrogen receptor (ER) and human epidermal growth factor receptor 2( HER2) expression. The biological subtypes have a spectrum of clinical, pathologic, and molecular features. Here, we investigated the correlation between the breast cancer subtype and chemosensitivity using the collagen gel droplet embedded culture drug sensitivity test (CD-DST). The response to 5-fluorouracil( 5-FU) was examined in 34 specimens;the response to epirubicin, in 35; and the response to paclitaxel, in 29. HER2 overexpression was not significantly correlated to the chemotherapeutic response to 5-FU, epirubicin, or paclitaxel. ER-positive breast cancer was significantly less sensitive to epirubicin and tended to be refractory to 5-FU and paclitaxel. The evaluation rate of the anti-drug sensitivity test was significantly lower in the group that received neoadjuvant chemotherapy. CD-DST could be useful in choosing anti-cancer drug agents for breast cancer patients.", "subitem_description_type": "Other"}]}, "item_2_description_15": {"attribute_name": "表示順", "attribute_value_mlt": [{"subitem_description": "5", "subitem_description_type": "Other"}]}, "item_2_description_16": {"attribute_name": "アクセション番号", "attribute_value_mlt": [{"subitem_description": "KJ00010012902", "subitem_description_type": "Other"}]}, "item_2_description_8": {"attribute_name": "記事種別(日)", "attribute_value_mlt": [{"subitem_description": "原著", "subitem_description_type": "Other"}]}, "item_2_source_id_1": {"attribute_name": "雑誌書誌ID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00629581", "subitem_source_identifier_type": "NCID"}]}, "item_2_source_id_19": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "03855023", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_6": {"attribute_name": "著者所属(日)", "attribute_value_mlt": [{"subitem_text_value": "獨協医科大学越谷病院 乳腺センター"}, {"subitem_text_value": "獨協医科大学越谷病院 乳腺センター"}, {"subitem_text_value": "獨協医科大学越谷病院 乳腺センター"}, {"subitem_text_value": "獨協医科大学越谷病院 乳腺センター"}]}, "item_2_text_7": {"attribute_name": "著者所属(英)", "attribute_value_mlt": [{"subitem_text_language": "en", "subitem_text_value": "Breast Center, Dokkyo Medical University Koshigaya Hospital"}, {"subitem_text_language": "en", "subitem_text_value": "Breast Center, Dokkyo Medical University Koshigaya Hospital"}, {"subitem_text_language": "en", "subitem_text_value": "Breast Center, Dokkyo Medical University Koshigaya Hospital"}, {"subitem_text_language": "en", "subitem_text_value": "Breast Center, Dokkyo Medical University Koshigaya Hospital"}]}, "item_2_title_3": {"attribute_name": "論文名よみ", "attribute_value_mlt": [{"subitem_title": "CD-DST ホウ オ モチイタ ニュウガン INTRINSIC SUBTYPES ニ オケル コウガンザイ カンジュ セイ シケン ノ ケントウ"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "林原, 紀明"}, {"creatorName": "ハヤシバラ, ノリアキ", "creatorNameLang": "ja-Kana"}], "nameIdentifiers": [{"nameIdentifier": "6320", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小川, 利久"}, {"creatorName": "オガワ, トシヒサ", "creatorNameLang": "ja-Kana"}], "nameIdentifiers": [{"nameIdentifier": "6321", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻, 英一"}, {"creatorName": "ツジ, エイイチ", "creatorNameLang": "ja-Kana"}], "nameIdentifiers": [{"nameIdentifier": "6322", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "石綱, 一央"}, {"creatorName": "イシヅナ, カズオ", "creatorNameLang": "ja-Kana"}], "nameIdentifiers": [{"nameIdentifier": "6323", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hayashibara, Noriaki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6324", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ogawa, Toshihisa", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6325", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuji, Eiichi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6326", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ishizuna, Kazuo", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6327", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-05-24"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "KJ00010012902.pdf", "filesize": [{"value": "609.5 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 609500.0, "url": {"label": "KJ00010012902.pdf", "url": "https://dmu.repo.nii.ac.jp/record/1273/files/KJ00010012902.pdf"}, "version_id": "1c5bd7af-400c-447c-a782-ea584c86ed49"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "抗癌剤感受性", "subitem_subject_scheme": "Other"}, {"subitem_subject": "CD-DST法", "subitem_subject_scheme": "Other"}, {"subitem_subject": "乳癌サブタイプ", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ホルモンレセプター", "subitem_subject_scheme": "Other"}, {"subitem_subject": "HER2過剰発現", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Cd-dst", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Intrinsic Subtypes", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Her2 Overexpression", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Estrogen Receptor", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Chemosensitivity", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "CD-DST法を用いた乳癌intrinsic subtypesにおける抗癌剤感受性試験の検討", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "CD-DST法を用いた乳癌intrinsic subtypesにおける抗癌剤感受性試験の検討"}, {"subitem_title": "Breast Cancer Subtypes and anti-cancer Drug Sensitivity Based on a Collagen Gel Droplet Embedded Culture Drug Sensitivity Test", "subitem_title_language": "en"}]}, "item_type_id": "2", "owner": "3", "path": ["75"], "permalink_uri": "https://dmu.repo.nii.ac.jp/records/1273", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-05-24"}, "publish_date": "2017-05-24", "publish_status": "0", "recid": "1273", "relation": {}, "relation_version_is_last": true, "title": ["CD-DST法を用いた乳癌intrinsic subtypesにおける抗癌剤感受性試験の検討"], "weko_shared_id": 3}
CD-DST法を用いた乳癌intrinsic subtypesにおける抗癌剤感受性試験の検討
https://dmu.repo.nii.ac.jp/records/1273
https://dmu.repo.nii.ac.jp/records/1273597f3148-1582-4b26-9d89-967c69c5a2bc
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | [ELS]学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-05-24 | |||||
タイトル | ||||||
タイトル | CD-DST法を用いた乳癌intrinsic subtypesにおける抗癌剤感受性試験の検討 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | Breast Cancer Subtypes and anti-cancer Drug Sensitivity Based on a Collagen Gel Droplet Embedded Culture Drug Sensitivity Test | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題 | 抗癌剤感受性 | |||||
キーワード | ||||||
主題 | CD-DST法 | |||||
キーワード | ||||||
主題 | 乳癌サブタイプ | |||||
キーワード | ||||||
主題 | ホルモンレセプター | |||||
キーワード | ||||||
主題 | HER2過剰発現 | |||||
キーワード | ||||||
言語 | en | |||||
主題 | Cd-dst | |||||
キーワード | ||||||
言語 | en | |||||
主題 | Intrinsic Subtypes | |||||
キーワード | ||||||
言語 | en | |||||
主題 | Her2 Overexpression | |||||
キーワード | ||||||
言語 | en | |||||
主題 | Estrogen Receptor | |||||
キーワード | ||||||
言語 | en | |||||
主題 | Chemosensitivity | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
雑誌書誌ID | ||||||
収録物識別子 | AA00629581 | |||||
論文名よみ | ||||||
タイトル | CD-DST ホウ オ モチイタ ニュウガン INTRINSIC SUBTYPES ニ オケル コウガンザイ カンジュ セイ シケン ノ ケントウ | |||||
著者 |
林原, 紀明
× 林原, 紀明× 小川, 利久× 辻, 英一× 石綱, 一央× Hayashibara, Noriaki× Ogawa, Toshihisa× Tsuji, Eiichi× Ishizuna, Kazuo |
|||||
著者所属(日) | ||||||
獨協医科大学越谷病院 乳腺センター | ||||||
著者所属(日) | ||||||
獨協医科大学越谷病院 乳腺センター | ||||||
著者所属(日) | ||||||
獨協医科大学越谷病院 乳腺センター | ||||||
著者所属(日) | ||||||
獨協医科大学越谷病院 乳腺センター | ||||||
著者所属(英) | ||||||
en | ||||||
Breast Center, Dokkyo Medical University Koshigaya Hospital | ||||||
著者所属(英) | ||||||
en | ||||||
Breast Center, Dokkyo Medical University Koshigaya Hospital | ||||||
著者所属(英) | ||||||
en | ||||||
Breast Center, Dokkyo Medical University Koshigaya Hospital | ||||||
著者所属(英) | ||||||
en | ||||||
Breast Center, Dokkyo Medical University Koshigaya Hospital | ||||||
記事種別(日) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 原著 | |||||
抄録(日) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 乳癌の個別化治療が進む中で,依然としてエストロゲンレセプター (ER) やHER2遺伝子の発現状況と化学療法の薬剤感受性との関係には不明な点が多い.今回我々はCollagen gel Droplet embedded culture Drug Sensitivity Test (CD-DST法) を用いた抗癌剤感受性試験を行い,乳癌のsubtypeと薬剤感受性の関係について検討を行った.対象は乳癌患者60例59検体で,5-FUは34検体,epirubicinは35検体,paclitaxelは29検体で抗癌剤感受性の評価が可能であった.5-FU,epirubicin,paclitaxelいずれの薬剤においてもHER2発現状況と抗癌剤感受性との間に有意な相関は認められなかった.ERの発現を認めるホルモン陽性乳癌ではepirubicinに対する薬剤感受性が有意に低下し,5-FU,paclitaxelに対しても感受性が低い傾向が認められた.術前化学療法施行例では抗癌剤感受性試験の評価可能率が低下する事が判明した.CD-DST法は今後の乳癌化学療法を選択する上で,有用となりうる可能性が示唆された. | |||||
抄録(英) | ||||||
内容記述タイプ | Other | |||||
内容記述 | Breast cancer is classified into four subtypes according to estrogen receptor (ER) and human epidermal growth factor receptor 2( HER2) expression. The biological subtypes have a spectrum of clinical, pathologic, and molecular features. Here, we investigated the correlation between the breast cancer subtype and chemosensitivity using the collagen gel droplet embedded culture drug sensitivity test (CD-DST). The response to 5-fluorouracil( 5-FU) was examined in 34 specimens;the response to epirubicin, in 35; and the response to paclitaxel, in 29. HER2 overexpression was not significantly correlated to the chemotherapeutic response to 5-FU, epirubicin, or paclitaxel. ER-positive breast cancer was significantly less sensitive to epirubicin and tended to be refractory to 5-FU and paclitaxel. The evaluation rate of the anti-drug sensitivity test was significantly lower in the group that received neoadjuvant chemotherapy. CD-DST could be useful in choosing anti-cancer drug agents for breast cancer patients. | |||||
書誌情報 |
Dokkyo journal of medical sciences 巻 42, 号 3, p. 143-150, 発行日 2015-10-25 |
|||||
ISSN | ||||||
収録物識別子 | 03855023 |